FPRX Market Cap History

Below is a table of the FPRX market cap history going back to 9/18/2013:

Date FPRX Market Cap

Also see: FPRX Shares Outstanding History
and FPRX YTD Return
FPRX Historical Market Cap:
+33.79% CAGR
FPRX Historical Market Cap: +33.79% CAGR

Mouse over chart for data details
9/18/2013 ...3/15/2021
Five Prime Therapeutics is a clinical-stage biotechnology company focused on developing immune modulators and therapies for patients with solid tumor cancers. Co.'s primary focus is on developing immuno-oncology and targeted cancer therapies. Co.'s product candidate Bemarituzumab (FPA144) is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, and that induces antibody-dependent cellular cytotoxicity. Co.'s product candidate also include FPA150, an antibody that targets B7-H4 that Co. is studying in a clinical trial to treat patients with cancers that overexpress B7-H4; and FPT155, a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28. We show 32 historical shares outstanding datapoints in our FPRX shares outstanding history coverage, used to compute FPRX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FPRX market cap history over the course of time is important for investors interested in comparing FPRX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FPRX versus a peer is one thing; comparing FPRX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FPRX can fluctuate over the course of history. With this page we aim to empower investors researching FPRX by allowing them to research the FPRX market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree FPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Five Prime Therapeutics (FPRX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

FREQ Market Cap History
FRTX Market Cap History
FSTX Market Cap History
FTRE Market Cap History
FTSV Market Cap History
FULC Market Cap History
FVE Market Cap History
FWBI Market Cap History
GALT Market Cap History
GANX Market Cap History
More Healthcare companies »


FPRX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.